Picton Mahoney Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-289,736
Closed -$7.21M 1375
2025
Q4
$7.21M Buy
289,736
+89,001
+44% +$2.24M 0.06% 264
2025
Q3
$5.12M Buy
+200,735
New +$4.95M 0.05% 277
2016
Q3
Sell
-342,023
Closed -$11.4M 336
2016
Q2
$11.4M Buy
342,023
+299,020
+695% +$9.54M 0.7% 45
2016
Q1
$1.21M Buy
43,003
+31,725
+281% +$906K 0.08% 166
2015
Q4
$346K Hold
11,278
0.02% 203
2015
Q3
$336K Buy
11,278
+3,268
+41% +$105K 0.02% 193
2015
Q2
$255K Hold
8,010
0.01% 201
2015
Q1
$265K Buy
+8,010
New +$255K 0.01% 192
2014
Q3
Sell
-453,009
Closed -$12.8K 348
2014
Q2
$12.8K Sell
453,009
-401,785
-47% -$11.5M 0.75% 48
2014
Q1
$26.1M Buy
854,794
+111,513
+15% +$3.32M 1.51% 13
2013
Q4
$21.6M Buy
743,281
+738,380
+15,066% +$21.5M 1.26% 15
2013
Q3
$134K Sell
4,901
-10,540
-68% -$287K 0.01% 248
2013
Q2
$410K Buy
+15,441
New +$427K 0.03% 223

Other funds holding PFE

Picton Mahoney Asset Management's PFE Position: Q1 2026 in Review

Picton Mahoney Asset Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 289,736 shares — an estimated $7.21M sold.

Picton Mahoney Asset Management first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $26.1M in Q1 2014. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Picton Mahoney Asset Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 289,736 Pfizer shares in Q1 2026, an estimated $7.21M.
  • Picton Mahoney Asset Management first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
  • Picton Mahoney Asset Management's Pfizer position peaked at $26.1M in Q1 2014.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2026, filed 13 May 2026.